Pharma Industry News

A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.

globenewswire.com - Zealand Pharma - Zealand Pharma - Transactions related to share buy-back program (week 31, 2026)
Zealand Pharma - Transactions related to share buy-back program (week 31, 2026)
GlobeNewswire

Company announcement No. 36 / 2026 Zealand Pharma - Transactions related to share buy-back program (week 31, 2026) Copenhagen, Denmark, August 3, 2026 – Zealand Pharma A/S ('the Company' or “Zealand Pharma”) (Nasdaq: ZEAL)…

bloomberg.com - Ashleigh Furlong - Why a Potential Astra-Bristol Merger Looks Like Pharma's FIFA Moment
Why a Potential Astra-Bristol Merger Looks Like Pharma's FIFA Moment
Bloomberg

This article is for subscribers only. Hi, it's Ashleigh Furlong in London and Sonja Wind in Frankfurt, looking at the immediate reaction to news of a potential megamerger in the global pharmaceuticals industry. Also today, Italy's Prysmian extends…

fool.com - TMF Breakfast News - Breakfast News: Pharma's $400B Blockbuster Brewing
Breakfast News: Pharma's $400B Blockbuster Brewing
The Motley Fool

Fuel cell maker Bloom Energy (BE -0.63%) entered the Supernova Odyssey portfolio in December, just as it was becoming a critical supplier of power generation to the data center buildout. Following a drawdown from its November 2025 high, the stock…

axios.com - Dan Primack - Pharma giants AstraZeneca and Bristol-Myers in reported merger talks
Pharma giants AstraZeneca and Bristol-Myers in reported merger talks
Axios

AstraZeneca has had merger talks with Bristol-Myers Squibb, according to the Financial Times. Why it matters: A tie-up would create the world's fourth most valuable drugmaker, with around $400 billion in combined market cap. Investor reax:…

zerohedge.com - Tyler Durden - $400 Billion Pharma Megadeal? Jefferies Calls Potential AstraZeneca-Bristol Myers Merger A 'Head Scratcher'
$400 Billion Pharma Megadeal? Jefferies Calls Potential AstraZeneca-Bristol Myers Merger A 'Head Scratcher'
Zero Hedge

The Financial Times reported overnight that AstraZeneca has explored acquiring Bristol Myers Squibb in a potential megadeal that would create one of the world's largest drugmakers, with a combined market capitalization of nearly $400 billion. The…

thehindubusinessline.com - GSK Pharma Q1 profit up 16% at ₹237.18 cr
GSK Pharma Q1 profit up 16% at ₹237.18 cr
BusinessLine

GlaxoSmithKline Pharmaceuticals Ltd on Monday reported a 16 per cent rise in consolidated net profit to ₹237.18 crore in the first quarter ended June 30, 2026. The company had posted a consolidated net profit of ₹205 crore in the…

thehindubusinessline.com - Sun Pharma voluntarily recalls 11 eyedrops from domestic market, experts seek details
Sun Pharma voluntarily recalls 11 eyedrops from domestic market, experts seek details
BusinessLine

Drugmaker Sun Pharmaceutical Industries has undertaken a voluntary recall of some of its ophthalmic products in the domestic market, with reports suggesting that 11 eyedrops were withdrawn. While the voluntary action is being appreciated, public…

thehindubusinessline.com - Iran talks, crude crash fuel midday rally; IT joins financials at the top, pharma bleeds
Iran talks, crude crash fuel midday rally; IT joins financials at the top, pharma bleeds
BusinessLine

Markets held firm through the first half of Monday's session, with the Sensex trading at 78,719.67, up 625.03 points or 0.80 per cent, and the Nifty 50 at 24,588.35, up 204.75 points or 0.84 per cent, as of 1.30 PM. The gains, which built on a…

thehindubusinessline.com - Sensex, Nifty gap up on Iran diplomacy, crude slide; financials lead, pharma drags
Sensex, Nifty gap up on Iran diplomacy, crude slide; financials lead, pharma drags
BusinessLine

Benchmarks opened sharply higher on Monday, August 3, 2026, as easing geopolitical tensions in West Asia and a fall in crude oil prices lifted investor sentiment across the financial and consumer sectors, even as pharmaceutical and auto stocks…

marketbeat.com - Carmignac Gestion Purchases Shares of 631,200 Royalty Pharma PLC $RPRX
Carmignac Gestion Purchases Shares of 631,200 Royalty Pharma PLC $RPRX
MarketBeat

Carmignac Gestion purchased a new position in shares of Royalty Pharma PLC (NASDAQ:RPRX - Free Report) during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm purchased…

marketbeat.com - OKYO Pharma (OKYO) Expected to Post Quarterly Earnings on Monday
OKYO Pharma (OKYO) Expected to Post Quarterly Earnings on Monday
MarketBeat

OKYO Pharma (NASDAQ:OKYO - Get Free Report) is expected to post its Q4 2026 results after the market closes on Monday, August 10th. Analysts expect the company to announce earnings of ($0.04) per share for the quarter. Individuals may visit the the…

marketbeat.com - Defilade Capital Management L.P. Lowers Position in Ascendis Pharma A/S $ASND
Defilade Capital Management L.P. Lowers Position in Ascendis Pharma A/S $ASND
MarketBeat

Defilade Capital Management L.P. lessened its holdings in shares of Ascendis Pharma A/S (NASDAQ:ASND - Free Report) by 39.4% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission.

marketbeat.com - Zealand Pharma A/S (OTCMKTS:ZLDPF) Shares Gap Up - Time to Buy?
Zealand Pharma A/S (OTCMKTS:ZLDPF) Shares Gap Up - Time to Buy?
MarketBeat

Zealand Pharma A/S (OTCMKTS:ZLDPF - Get Free Report) gapped up before the market opened on Monday. The stock had previously closed at $45.02, but opened at $47.50. Zealand Pharma A/S shares last traded at $47.50, with a volume of 212 shares trading…

marketbeat.com - Quantinno Capital Management LP Buys 41,417 Shares of Royalty Pharma PLC $RPRX
Quantinno Capital Management LP Buys 41,417 Shares of Royalty Pharma PLC $RPRX
MarketBeat

Quantinno Capital Management LP increased its position in Royalty Pharma PLC (NASDAQ:RPRX - Free Report) by 12.1% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm…

wsj.com - Health Care Roundup: Market Talk
Health Care Roundup: Market Talk
Wall Street Journal

The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET. 0811 GMT – A potential tie-up between AstraZeneca and Bristol Myers Squibb could face antitrust hurdles…

Receive a Daily briefing on Pharma Industry News

Get Started